BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang L, Xu L, Mao J, Li J, Fang L, Zhou Y, Liu W, He W, Zhao AZ, Yang J, Dai C. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. J Am Soc Nephrol 2013;24:1114-26. [PMID: 23661807 DOI: 10.1681/ASN.2012050476] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Xia ZE, Xi JL, Shi L. 3,3'-Diindolylmethane ameliorates renal fibrosis through the inhibition of renal fibroblast activation in vivo and in vitro. Ren Fail 2018;40:447-54. [PMID: 30101622 DOI: 10.1080/0886022X.2018.1490322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yang B, Chen S, Wu M, Zhang L, Ruan M, Chen X, Chen Z, Mei C, Mao Z. PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury. Sci Rep 2017;7:39888. [PMID: 28045076 DOI: 10.1038/srep39888] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Heard JJ, Fong V, Bathaie SZ, Tamanoi F. Recent progress in the study of the Rheb family GTPases. Cell Signal 2014;26:1950-7. [PMID: 24863881 DOI: 10.1016/j.cellsig.2014.05.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
4 Yang Z, Zhang Y, Sun S. Deciphering the SUMO code in the kidney. J Cell Mol Med 2019;23:711-9. [PMID: 30506859 DOI: 10.1111/jcmm.14021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ke Q, Shi C, Lv Y, Wang L, Luo J, Jiang L, Yang J, Zhou Y. SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney. FASEB J 2022;36:e22078. [PMID: 34918381 DOI: 10.1096/fj.202100909RR] [Reference Citation Analysis]
6 Liu M, Ning X, Li R, Yang Z, Yang X, Sun S, Qian Q. Signalling pathways involved in hypoxia-induced renal fibrosis. J Cell Mol Med 2017;21:1248-59. [PMID: 28097825 DOI: 10.1111/jcmm.13060] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 16.2] [Reference Citation Analysis]
7 Shigematsu T, Tajima S, Fu R, Zhang M, Itoyama Y, Tsuchimoto A, Egashira N, Ieiri I. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sci 2021;288:120150. [PMID: 34793770 DOI: 10.1016/j.lfs.2021.120150] [Reference Citation Analysis]
8 Xing G, Luo Z, Zhong C, Pan X, Xu X. Influence of miR-155 on Cell Apoptosis in Rats with Ischemic Stroke: Role of the Ras Homolog Enriched in Brain (Rheb)/mTOR Pathway. Med Sci Monit 2016;22:5141-53. [PMID: 28025572 DOI: 10.12659/msm.898980] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
9 Grahammer F. Halting renal fibrosis: an unexpected role for mTORC2 signaling. Kidney Int 2015;88:437-9. [PMID: 26323069 DOI: 10.1038/ki.2015.137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
10 Andrikopoulos P, Kieswich J, Pacheco S, Nadarajah L, Harwood SM, O'Riordan CE, Thiemermann C, Yaqoob MM. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling. J Am Soc Nephrol 2019;30:33-49. [PMID: 30530834 DOI: 10.1681/ASN.2018020209] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
11 Gu M, Tan M, Zhou L, Sun X, Lu Q, Wang M, Jiang H, Liang Y, Hou Q, Xue X, Xu Z, Dai C. Protein phosphatase 2Acα modulates fatty acid oxidation and glycolysis to determine tubular cell fate and kidney injury. Kidney Int 2022:S0085-2538(22)00343-X. [PMID: 35483524 DOI: 10.1016/j.kint.2022.03.024] [Reference Citation Analysis]
12 Lu Q, Wang M, Gui Y, Hou Q, Gu M, Liang Y, Xiao B, Zhao AZ, Dai C. Rheb1 protects against cisplatin-induced tubular cell death and acute kidney injury via maintaining mitochondrial homeostasis. Cell Death Dis 2020;11:364. [PMID: 32404875 DOI: 10.1038/s41419-020-2539-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ke Q, Yuan Q, Qin N, Shi C, Luo J, Fang Y, Xu L, Sun Q, Zen K, Jiang L, Zhou Y, Yang J. UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury. Cell Death Dis 2020;11:26. [PMID: 31932578 DOI: 10.1038/s41419-019-2219-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zhou L, Liu S, Han M, Ma Y, Feng S, Zhao J, Lu H, Yuan X, Cheng J. miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis. Mol Ther Nucleic Acids 2018;10:91-102. [PMID: 29499960 DOI: 10.1016/j.omtn.2017.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
15 Huang J, Gu S, Chen M, Zhang SJ, Jiang Z, Chen X, Jiang C, Liu G, Radu RA, Sun X, Vollrath D, Du J, Yan B, Zhao C. Abnormal mTORC1 signaling leads to retinal pigment epithelium degeneration. Theranostics 2019;9:1170-80. [PMID: 30867823 DOI: 10.7150/thno.26281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
16 Gui Y, Dai C. mTOR Signaling in Kidney Diseases. Kidney360 2020;1:1319-27. [DOI: 10.34067/kid.0003782020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Nishioka S, Ishimura T, Endo T, Yokoyama N, Ogawa S, Fujisawa M. Suppression of Allograft Fibrosis by Regulation of Mammalian Target of Rapamycin-Related Protein Expression in Kidney-Transplanted Recipients Treated with Everolimus and Reduced Tacrolimus. Ann Transplant 2021;26:e926476. [PMID: 33431785 DOI: 10.12659/AOT.926476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rojas-Morales P, Tapia E, León-Contreras JC, González-Reyes S, Jiménez-Osorio AS, Trujillo J, Pavón N, Granados-Pineda J, Hernández-Pando R, Sánchez-Lozada LG, Osorio-Alonso H, Pedraza-Chaverri J. Mechanisms of Fasting-Mediated Protection against Renal Injury and Fibrosis Development after Ischemic Acute Kidney Injury. Biomolecules 2019;9:E404. [PMID: 31443530 DOI: 10.3390/biom9090404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
19 Yin W, Naini SM, Chen G, Hentschel DM, Humphreys BD, Bonventre JV. Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model. J Am Soc Nephrol 2016;27:1943-57. [PMID: 26538632 DOI: 10.1681/ASN.2015050500] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
20 Li J, Ren J, Liu X, Jiang L, He W, Yuan W, Yang J, Dai C. Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis. Kidney Int 2015;88:515-27. [PMID: 25970154 DOI: 10.1038/ki.2015.119] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
21 Nakano T, Watanabe H, Imafuku T, Tokumaru K, Fujita I, Arimura N, Maeda H, Tanaka M, Matsushita K, Fukagawa M, Maruyama T. Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway. Toxins 2021;13:909. [DOI: 10.3390/toxins13120909] [Reference Citation Analysis]
22 Zhong L, Yao L, Holdreith N, Yu W, Gui T, Miao Z, Elkaim Y, Li M, Gong Y, Pacifici M, Maity A, Busch TM, Joeng KS, Cengel K, Seale P, Tong W, Qin L. Transient expansion and myofibroblast conversion of adipogenic lineage precursors mediate bone marrow repair after radiation. JCI Insight 2022;7:e150323. [PMID: 35393948 DOI: 10.1172/jci.insight.150323] [Reference Citation Analysis]
23 Chen F, Sheng L, Xu C, Li J, Ali I, Li H, Cai Y. Ufbp1, a Key Player of Ufm1 Conjugation System, Protects Against Ketosis-Induced Liver Injury via Suppressing Smad3 Activation. Front Cell Dev Biol 2021;9:676789. [PMID: 34307359 DOI: 10.3389/fcell.2021.676789] [Reference Citation Analysis]
24 Zeng Z, Yang H, Wang Y, Ren J, Dai Y, Dai C. Omega-3 Polyunsaturated Fatty Acids Attenuate Fibroblast Activation and Kidney Fibrosis Involving MTORC2 Signaling Suppression. Sci Rep 2017;7:46146. [PMID: 28393852 DOI: 10.1038/srep46146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
25 Xue X, Ren J, Sun X, Gui Y, Feng Y, Shu B, Wei W, Lu Q, Liang Y, He W, Yang J, Dai C. Protein kinase Cα drives fibroblast activation and kidney fibrosis by stimulating autophagic flux. J Biol Chem 2018;293:11119-30. [PMID: 29794026 DOI: 10.1074/jbc.RA118.002191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
26 Feng Y, Ren J, Gui Y, Wei W, Shu B, Lu Q, Xue X, Sun X, He W, Yang J, Dai C. Wnt/β-Catenin-Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis. J Am Soc Nephrol 2018;29:182-93. [PMID: 29021383 DOI: 10.1681/ASN.2017040391] [Cited by in Crossref: 64] [Cited by in F6Publishing: 44] [Article Influence: 12.8] [Reference Citation Analysis]
27 Fantus D, Rogers NM, Grahammer F, Huber TB, Thomson AW. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. Nat Rev Nephrol 2016;12:587-609. [PMID: 27477490 DOI: 10.1038/nrneph.2016.108] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 14.2] [Reference Citation Analysis]
28 Ren J, Li J, Liu X, Feng Y, Gui Y, Yang J, He W, Dai C. Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and β-catenin Signaling. Sci Rep 2016;6:23968. [PMID: 27052477 DOI: 10.1038/srep23968] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
29 Gui Y, Lu Q, Gu M, Wang M, Liang Y, Zhu X, Xue X, Sun X, He W, Yang J, Zhao AZ, Xiao B, Dai C. Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury. Cell Death Differ 2019;26:2774-89. [PMID: 31024074 DOI: 10.1038/s41418-019-0336-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
30 He W, Dai C. Key Fibrogenic Signaling. Curr Pathobiol Rep 2015;3:183-92. [PMID: 25973345 DOI: 10.1007/s40139-015-0077-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
31 Xu CG, Zhu XL, Wang W, Zhou XJ. Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo. Pharm Biol 2019;57:169-75. [PMID: 30905239 DOI: 10.1080/13880209.2019.1577464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
32 You YK, Huang XR, Chen HY, Lyu XF, Liu HF, Lan HY. C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway. Sci Rep 2016;6:26740. [PMID: 27221338 DOI: 10.1038/srep26740] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
33 Nistala R, Raja A, Pulakat L. mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF rats. Can J Physiol Pharmacol 2017;95:281-7. [PMID: 28177677 DOI: 10.1139/cjpp-2016-0567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
34 Xu Z, Dai C. Ablation of FGFR2 in Fibroblasts Ameliorates Kidney Fibrosis after Ischemia/Reperfusion Injury in Mice. Kidney Dis (Basel) 2017;3:160-70. [PMID: 29344510 DOI: 10.1159/000484604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
35 Liu Y, Zhong W, Zhang J, Chen W, Lu Y, Qiao Y, Zeng Z, Huang H, Cai S, Dong H. Tetrandrine Modulates Rheb-mTOR Signaling-Mediated Selective Autophagy and Protects Pulmonary Fibrosis. Front Pharmacol 2021;12:739220. [PMID: 34880752 DOI: 10.3389/fphar.2021.739220] [Reference Citation Analysis]
36 Shan L, Ding Y, Fu Y, Zhou L, Dong X, Chen S, Wu H, Nai W, Zheng H, Xu W, Bai X, Jia C, Dai M. mTOR Overactivation in Mesenchymal cells Aggravates CCl4- Induced liver Fibrosis. Sci Rep 2016;6:36037. [PMID: 27819329 DOI: 10.1038/srep36037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]